InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-21.6%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Thomas Bonnefont, COO & CCO. Officer active across 1 company, notably Median Technologies. Cumulatively, 2 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €67k. Activity tracked since 21 October 2022. The latest transaction was filed on 21 October 2023 (Acquisition). Regulator: AMF. All data is free.
Declarations2 total
15,000 shares@ €4.45100.0% of flowActionEuronext Paris2023DD942067
Ideal exit: 17 Jul 2024 (T+270)
15,000 shares0actions gratuitesHors plateforme de négociation2022DD872047
Ideal exit: 18 Jul 2023 (T+270)
2 of 2 declarations
About Thomas Bonnefont
Thomas Bonnefont is the COO and CCO of Eyonis and iBiopsy. In these roles, he is responsible for the operations and business development of the companies. Thomas works on optimizing operational processes and implementing growth strategies. His expertise in the sector is essential for the success of Eyonis and iBiopsy's initiatives.
